Reducing the effective dose of cisplatin using gold nanoparticles as carriers

Published on Dec 1, 2020in Cancer Nanotechnology4.7
· DOI :10.1186/S12645-020-00060-W
M. A. González-López1
Estimated H-index: 1
,
E. M. Gutiérrez-Cárdenas1
Estimated H-index: 1
(UAM: Universidad Autónoma Metropolitana)
+ 4 AuthorsO. Hernández-González1
Estimated H-index: 1
Sources
Abstract
Nanotechnology is a frequent treatment for cancer. Nanomaterials are the vehicles which deliver drugs in smaller but equally effective quantities. The aim of this investigation is to synthesize gold nanoparticles, functionalize them for the transportation of cisplatin and release them to the cancer-affected area. They have the same cytotoxicity as conventional treatments but with the smallest effective quantity of cisplatin. We synthesized spherical gold nanoparticles using the Turkevich method. We functionalized them with polyethylene glycol and cisplatin, adapting the method used by Sun. Using electronic transmission microscopy, Dynamic Light Scattering and potential Z, we analyzed the size, hydrodynamic size, shape and stability of the synthesized nanoparticles. We analyzed their composition using images from scanning electronic microscopy to carry out energy dispersive spectroscopy measurements, ultraviolet/visible light spectroscopy and Fourier transform infrared spectroscopy. We used MTT tests to find cell viability and obtained the IC50 of the different cancer cell lines. The synthesized nanoparticles were spherical in shape and, after functionalization, were of the core–shell type. They contain approximately 7% cisplatin. The IC50 obtained diminished approximately 7 times (compared to the IC50 of cisplatin used alone) when using the gold nanoparticles. Therefore, this study opens up the possibility of an alternative way of transporting the cisplatin anticancer drug, using gold nanoparticles. It decreases the dose and has the same effect as the cisplatin, so that the undesired side effects decrease.
📖 Papers frequently viewed together
105 Citations
24 Citations
2016
4 Citations
References41
Newest
#1Luca GuerriniH-Index: 29
Last. Nicolas Pazos-PerezH-Index: 23
view all 3 authors...
Due to the high surface: volume ratio and the extraordinary properties arising from the nanoscale (optical, electric, magnetic, etc.), nanoparticles (NPs) are excellent candidates for multiple applications. In this context, nanoscience is opening a wide range of modern technologies in biological and biomedical fields, among others. However, one of the main drawbacks that still delays its fast evolution and effectiveness is related to the behavior of nanomaterials in the presence of biological fl...
137 CitationsSource
#1M. Danaei (Monash University)H-Index: 3
#2M Dehghankhold (Monash University)H-Index: 1
Last. Mohammad Reza Mozafari (Monash University)H-Index: 23
view all 8 authors...
Lipid-based drug delivery systems, or lipidic carriers, are being extensively employed to enhance the bioavailability of poorly-soluble drugs. They have the ability to incorporate both lipophilic and hydrophilic molecules and protecting them against degradation in vitro and in vivo. There is a number of physical attributes of lipid-based nanocarriers that determine their safety, stability, efficacy, as well as their in vitro and in vivo behaviour. These include average particle size/diameter and...
681 CitationsSource
#1Saeed Ahmad (Salman bin Abdulaziz University)H-Index: 9
#1Saeed AhmadH-Index: 23
Abstract Platinum(II) compounds, such as cis-[Pt(NH3)2Cl2] (cisplatin) are well known for their use as anticancer drugs. The antitumor activity of platinum drugs is attributed to their ability to bind to DNA causing its damage and subsequently inducing apoptosis in cancer cells. The kinetics of ligand exchange around platinum plays a crucial role in the activity of platinum complexes. Aquation of cisplatin to cis-[Pt(NH3)2(H2O)Cl]+ is usually the first step in cisplatin binding to DNA. The monoh...
27 CitationsSource
#1Mine Altunbek (Yeditepe University)H-Index: 10
#2Mustafa Culha (Yeditepe University)H-Index: 29
The conventional colorimetric assays based on measurement of the metabolic activity are routinely used to evaluate the cytotoxicity of nanomaterials (NMs). However, due to the varying absorbance properties of plasmonic NMs in the visible region of the spectrum, obtained results can be misleading. In this study, MTT, MTS, and WST-1 colorimetric cell viability assays were evaluated in the presence of gold (AuNPs) or silver nanoparticles (AgNPs). Since a living cell a complex system containing many...
4 CitationsSource
#1Dijendra Nath Roy (NITA: National Institute of Technology Agartala)H-Index: 10
#2Ritobrata Goswami (Ahmedabad University)H-Index: 15
Last. AK Pal (Tripura University)H-Index: 3
view all 3 authors...
Abstract1. In the last few years, a substantial scientific work is focused to identify the potential toxicity of nanomaterials by studying the cellular pathways under in vitro and in vivo conditions. Owing to high surface area to volume ratio nanoparticles (NPs) can pass through cell membranes which might be responsible for creating adverse interactions in biological systems. Simultaneously, researchers are also interested to assess the fate of NP inside the living system, which may lead to alte...
20 CitationsSource
#1Cláudia Couto (University of Aveiro)H-Index: 2
#2Rui Vitorino (University of Aveiro)H-Index: 39
Last. Ana L. Daniel-da-Silva (University of Aveiro)H-Index: 25
view all 3 authors...
In the last few years gold nanoparticles (AuNPs) became extremely interesting materials due to their enhanced optical, chemical and electrical properties. With the intention of taking advantage of those properties, the use of AuNPs has spread into a wide variety of areas such as physics, chemistry, biology, industry and medicine. More interestingly, their ability to form robust conjugates with biomolecules has given proteomics a new tool to improve aspects where the current methods to study prot...
21 CitationsSource
#1Gregory V. Lowry (CMU: Carnegie Mellon University)H-Index: 83
#2Reghan J. Hill (McGill University)H-Index: 24
Last. John RumbleH-Index: 4
view all 9 authors...
Nanoparticle zeta-potentials are relatively easy to measure, and have consistently been proposed in guidance documents as a particle property that must be included for complete nanoparticle characterization. There is also an increasing interest in integrating data collected on nanomaterial properties and behavior measured in different systems (e.g. in vitro assays, surface water, soil) to identify the properties controlling nanomaterial fate and effects, to be able to integrate and reuse dataset...
101 CitationsSource
#1Xinlong Wang (University of Tsukuba)H-Index: 16
#2Xiaohong Hu (University of Tsukuba)H-Index: 12
Last. Guoping Chen (University of Tsukuba)H-Index: 58
view all 7 authors...
Nanoparticles (NPs) have shown great potential for biomedical applications because of their unique physical and structural properties. A critical aspect for their clinical applications is cellular uptake that depends on both particle properties and the cell mechanical state. Despite the numerous studies trying to disclose the influencing factors, the role of cell size on cellular uptake remains unclear. In this study, poly(vinyl alcohol) was micropatterned on tissue culture polystyrene surfaces ...
39 CitationsSource
#1Jung Soo Suk (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 34
#2Qingguo Xu (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 21
Last. Laura M. Ensign (Johns Hopkins University)H-Index: 24
view all 5 authors...
Abstract Coating the surface of nanoparticles with polyethylene glycol (PEG), or “PEGylation”, is a commonly used approach for improving the efficiency of drug and gene delivery to target cells and tissues. Building from the success of PEGylating proteins to improve systemic circulation time and decrease immunogenicity, the impact of PEG coatings on the fate of systemically administered nanoparticle formulations has, and continues to be, widely studied. PEG coatings on nanoparticles shield the s...
1,281 CitationsSource
#1Timothy C. Johnstone (MIT: Massachusetts Institute of Technology)H-Index: 25
#2Kogularamanan Suntharalingam ('KCL': King's College London)H-Index: 27
Last. Stephen J. Lippard (MIT: Massachusetts Institute of Technology)H-Index: 158
view all 3 authors...
The platinum drugs, cisplatin, carboplatin, and oxaliplatin, prevail in the treatment of cancer, but new platinum agents have been very slow to enter the clinic. Recently, however, there has been a surge of activity, based on a great deal of mechanistic information, aimed at developing nonclassical platinum complexes that operate via mechanisms of action distinct from those of the approved drugs. The use of nanodelivery devices has also grown, and many different strategies have been explored to ...
1,017 CitationsSource
Cited By3
Newest
#1Abdulaziz Alhussan (UVic: University of Victoria)H-Index: 1
#2Kyle Bromma (UVic: University of Victoria)H-Index: 7
Last. Devika B. ChithraniH-Index: 17
view all 7 authors...
Due to recent advances in nanotechnology, the application of nanoparticles (NPs) in cancer therapy has become a leading area in cancer research. Despite the importance of cancer-associated fibroblasts (CAFs) in creating an optimal niche for tumor cells to grow extensively, most of the work has been focused on tumor cells. Therefore, to effectively use NPs for therapeutic purposes, it is important to elucidate the extent of NP uptake and retention in tumor cells and CAFs. Three tumor cell lines a...
Source
About half of cancer patients (50%) receive radiotherapy (RT) for the treatment of local tumors. However, one of the main obstacles in RT is the close proximity of adjacent organs at risk, resulting in treatment doses being limited by significant tissue toxicity, hence preventing the necessary dose escalation that would guarantee local control. Effective local cancer therapy is needed to avoid progression of tumors and to decrease the development of systemic metastases which may further increase...
2 CitationsSource
#1Kyle Bromma (UVic: University of Victoria)H-Index: 7
#2Aaron Bannister (UVic: University of Victoria)H-Index: 3
Last. Devika B. Chithrani (UVic: University of Victoria)H-Index: 17
view all 5 authors...
Successful integration of nanotechnology into the current paradigm of cancer therapy requires proper understanding of the interface between nanoparticles (NPs) and cancer cells, as well as other key components within the tumor microenvironment (TME), such as normal fibroblasts (FBs) and cancer-associated FBs (CAFs). So far, much focus has been on cancer cells, but FBs and CAFs also play a critical role: FBs suppress the tumor growth while CAFs promote it. It is not yet known how NPs interact wit...
6 CitationsSource